Strattera 10mg, 18mg, 25mg, 40mg, 60mg, 80mg and 100mg hard capsules
*Company:
Eli Lilly and Company (Ireland) LimitedStatus:
DiscontinuedLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 16 February 2023
File name
Strattera-Caps_IE-UK-MT_PIL_ST047-2_Jan21.pdf
Reasons for updating
- Correction of spelling/typing errors
Free text change information supplied by the pharmaceutical company
Updated on 20 January 2023
File name
STRATTERA ROI SPC Jul18 ST37M.pdf
Reasons for updating
- Document format updated
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 03 May 2021
File name
Strattera-OS_IE-UK_PIL_ST048_Jan21-2.pdf
Reasons for updating
- Change to section 4 - how to report a side effect
- Change to MA holder contact details
Updated on 29 January 2021
File name
Strattera-Caps_IE-UK-MT_PIL_Jan21.pdf
Reasons for updating
- Change to section 4 - how to report a side effect
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
Updated on 29 January 2021
File name
Strattera-Caps_IE-UK-MT_PIL_Jan21.pdf
Reasons for updating
- Change to section 4 - how to report a side effect
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
Free text change information supplied by the pharmaceutical company
Change to UK marketing authorisation holder only. Update to latest ADR reporting requirements.
Updated on 29 July 2020
File name
ie-pil-en-caps-18.pdf
Reasons for updating
- XPIL Updated
Updated on 29 July 2020
File name
ie-pil-en-caps-18.pdf
Reasons for updating
- XPIL Updated
Updated on 28 July 2020
File name
ie-pil-en-caps-18.pdf
Reasons for updating
- XPIL Updated
Updated on 30 July 2018
File name
ie-pil-en-caps-18.pdf
Reasons for updating
- Change to section 6 - marketing authorisation holder
- Change to section 6 - marketing authorisation number
- Change to section 6 - date of revision
Updated on 30 July 2018
File name
STRATTERA ROI SPC Jul18 ST37M.pdf
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - Marketing authorisation number(s)
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Transfer of Marketing authorisation holder from Eli Lilly UK (Basingstoke) to Eli Lilly Netherlands
Updated on 09 May 2018
File name
STRATTERA-ROI-SPC-May15-ST35M.docx
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 27 April 2018
File name
STRATTERA-ROI-SPC-May15-ST35M.docx
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 23 April 2018
File name
Strattera_caps_PIL_UK-IE-MT May 15.pdf
Reasons for updating
- New PIL for new product